Laser Treatment for Improvement and Minimization of Facial Scars

Facial Plastic Surgery Clinics of North America

Volumn 19, Issue 3, 2011, Pages 527-542

  Sobanko, Joseph F ^a   Alster, Tina S ^b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WASHINGTON INSTITUTE OF DERMATOLOGIC LASER SURGERY   (United States)

Author keywords

Fractionated laser; Laser treatment; Pulsed dye laser; Scar revision

Indexed keywords

ANTIBIOTIC AGENT; BLEOMYCIN; CARBON DIOXIDE; COLLAGEN FIBER; CORTICOSTEROID; CYTOKINE; FLUOROURACIL; HISTAMINE; LIDOCAINE; TRIAMCINOLONE;

ACNE; APPLICATION SITE HYPERPIGMENTATION; CONTACT DERMATITIS; ECTROPION; ECZEMA; ERYTHEMA; HUMAN; KELOID; KERATOACANTHOMA; LASER; LASER SURGERY; POSTOPERATIVE PAIN; PSORIASIS; PULSED DYE LASER; PURPURA; RECALL; REVIEW; SCAR FORMATION; SKIN ABRASION; SKIN ATROPHY; SKIN HYPERTROPHY; SKIN PENETRATION; SKIN SCAR; SKIN TOXICITY; SUN EXPOSURE; TOPICAL ANESTHESIA; TREATMENT OUTCOME; WOUND HEALING;

CICATRIX; FACE; HUMANS; LASER THERAPY;

EID: 80051812032     PISSN: 10647406     EISSN: 15581926     Source Type: Journal    
DOI: 10.1016/j.fsc.2011.06.006     Document Type: Review

References (115)

1. Levine E., Degutis L., Pruzinsky T., et al. Quality of life and facial trauma: psychological and body image effects. Ann Plast Surg 2005, 54:502-510.
2. Robert R., Meyer W., Bishop S., et al. Disfiguring burn scars and adolescent self-esteem. Burns 1999, 25:581-585.
3. Tebble N.J., Adams R., Thomas D.W., et al. Anxiety and self-consciousness in patients with facial lacerations one week and six months later. Br J Oral Maxillofac Surg 2006, 44:520-525.
4. Bell L., McAdams T., Morgan R., et al. Pruritus in burns: a descriptive study. J Burn Care Rehabil 1988, 9:305-311.
5. Young V.L., Hutchison J. Insights into patient and clinician concerns about scar appearance: semiquantitative structured surveys. Plast Reconstr Surg 2009, 124:256-265.
6. Rumsey N., Clarke A., White P. Exploring the psychosocial concerns of outpatients with disfiguring conditions. J Wound Care 2003, 12:247-252.
7. Brown B.C., McKenna S.P., Siddhi K., et al. The hidden cost of skin scars: quality of life after skin scarring. J Plast Reconstr Aesthet Surg 2008, 61:1049-1058.
8. Urioste S.S., Arndt K.A., Dover J.S. Keloids and hypertrophic scars: review and treatment strategies. Semin Cutan Med Surg 1999, 18:159-171.
9. Monaco J.L., Lawrence W.T. Acute wound healing: an overview. Clin Plast Surg 2003, 30:1-12.
10. Reish R.G., Eriksson E. Scars: a review of emerging and currently available therapies. Plast Reconstr Surg 2008, 122:1068-1078.
11. Alster T.S., Tanzi E.L. Hypertrophic scars and keloids: etiology and management. Am J Clin Dermatol 2003, 4:235-243.
12. Ferguson M.W.J., Duncan J., Bond J., et al. Prophylactic administration of avotermin for improvement of skin scarring: three double-blind placebo-controlled phase I/II studies. Lancet 2009, 373:1264-1274.
13. Wu W.S., Wang F.S., Yang K.D., et al. Dexamethasone induction of keloid regression through effective suppression of VEGF expression and keloid fibroblast proliferation. J Invest Dermatol 2006, 126:1264-1271.
14. Mallick K.S., Hajek A.S., Parrish R.K. Fluorouracil (5-FU) and cytarabine (ara-C) inhibition of corneal epithelial cell and conjunctival fibroblast proliferation. Arch Ophthalmol 1985, 103:1398-1402.
15. Hendricks T., Martens M.F., Huyben C.M., et al. Inhibition of basal and TGF beta-induced fibroblast collagen synthesis by antineoplastic agents: implications for wound healing. Br J Cancer 1993, 67:545-550.
16. Asilian A., Darougheh A., Shariati F. New combination of triamcinolone, 5-fluorouracil, and pulsed-dye laser for treatment of keloid and hypertrophic scars. Dermatol Surg 2006, 32:907-915.
17. Fitzpatrick R.E. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999, 25:224-232.
18. Ragoowansi R., Cornes P.G., Moss A.L., et al. Treatment of keloids by surgical excision and immediate postoperative single-fraction radiotherapy. Plast Reconstr Surg 2003, 111:1853-1859.
19. Anderson R.R., Parrish J.A. Selective photothermolysis: precise microsurgery by selective absorption of pulsed radiation. Science 1983, 22:524-527.
20. Alster T.S., Kurban A.K., Grove G.L., et al. Alteration of argon laser-induced scars by the pulsed dye laser. Lasers Surg Med 1993, 13:368-373.
21. Powers P.S., Sarkar S., Goldgof D.B., et al. Scar assessment: current problems and future solutions. J Burn Care Rehabil 1999, 20:54-59.
22. Yeong E.K., Mann R., Engrav L.H., et al. Improved burn scar assessment with use of a new scar-rating scale. J Burn Care Rehabil 1997, 18:353-355.
23. Nedelec B., Shankowsky H.A., Tredget E.E. Rating the resolving hypertrophic scar: comparison of the Vancouver scar scale and scar volume. J Burn Care Rehabil 2000, 21:205-212.
24. Draaijers L.J., Templeman F.R.H., Botman Y.A.M., et al. The patient and observer scar assessment scale: a reliable and feasible tool for scar evaluation. Plast Reconstr Surg 2004, 113:1960-1965.
25. Idriss N., Maibach H.I. Scar assessment scales: a dermatologic overview. Skin Res Technol 2009, 15:1-5.
26. Jacob C.I., Dover J.S., Kaminer M.S. Acne scarring: a classification system and review of treatment options. J Am Acad Dermatol 2001, 45:109-117.
27. McCraw J.B., McCraw J.A., McMellin A., et al. Prevention of unfavorable scars using early pulsed dye laser treatments: a preliminary report. Ann Plast Surg 1999, 42:7-14.
28. Bowes L.E., Alster T.S. Treatment of facial scarring and ulceration resulting from acne excoriée with 585-nm pulsed dye laser irradiation and cognitive psychotherapy. Dermatol Surg 2004, 30:934-938.
29. Nouri K., Jimenez G.P., Harrison-Balestra C., et al. 585-nm pulsed dye laser in the treatment of surgical scars starting on the suture removal day. Dermatol Surg 2003, 29:65-73.
30. Pinheiro A.L., Pozza D.H., Oliveira M.G., et al. Polarized light (400-2000 nm) and non-ablative laser (685 nm): a description of the wound healing process using immunohistochemistry analysis. Photomed Laser Surg 2005, 23:485-492.
31. Bouzari N., Davis S.C., Nouri K. Laser treatment of keloids and hypertrophic scars. Int J Dermatol 2007, 46:80-88.
32. Alster T.S., Zaulyanov-Scanlon L. Laser scar revision: a review. Dermatol Surg 2007, 33:131-140.
33. Castro D.J., Abergel R.P., Meeker C., et al. Effects of the Nd:YAG laser on DNA synthesis and collagen production in human skin fibroblast cultures. Ann Plast Surg 1983, 11:214-222.
34. Abergel R.P., Meeker C.A., Lam T.S., et al. Control of connective tissue metabolism by lasers: recent developments and future prospects. J Am Acad Dermatol 1984, 11:1142-1150.
35. Henderson D.L., Cromwell T.A., Mes L.G. Argon and carbon dioxide laser treatment of hypertrophic and keloid scars. Lasers Surg Med 1984, 3:271.
36. Abergel R.P., Dwyer R.M., Meeker C.A., et al. Laser treatment of keloids: a clinical trial and an in vitro study with Nd:YAG laser. Lasers Surg Med 1984, 4:291-295.
37. Alster T.S., Williams C.M. Improvement of keloid sternotomy scars by the 585 nm pulsed dye laser: a controlled study. Lancet 1995, 345:1198-1200.
38. Alster T.S. Improvement of erythematous and hypertrophic scars by the 585 nm flashlamp-pumped pulsed dye laser. Ann Plast Surg 1994, 32(2):186-190.
39. Alster T.S., Nanni C.A. Pulsed dye laser treatment of hypertrophic burn scars. Plast Reconstr Surg 1998, 102:2190-2195.
40. Alster T.S., McMeekin T.O. Improvement of facial acne scars by the 585nm flashlamp-pumped pulsed dye laser. J Am Acad Dermatol 1996, 35:79-81.
41. Alster T.S. Laser treatment of scars and striae. Manual of cutaneous laser techniques 2000, 89-107. Lippincott- Raven, Philadelphia. T.S. Alster (Ed.).
42. Kuo Y.R., Jeng S.F., Wang F.S., et al. Flashlamp pulsed dye laser (PDL) suppression of keloid proliferation through down-regulation of TGF-beta1 expression and extracellular matrix expression. Lasers Surg Med 2004, 34:104-108.
43. Reiken S.R., Wolfort S.F., Berthiamume F., et al. Control of hypertrophic scar growth using selective photothermolysis. Lasers Surg Med 1997, 21:7-12.
44. Manuskiatti W., Wanitphakdeedecha R., Fitzpatrick R.E. Effect of pulse width of a 595-nm flashlamp-pumped pulsed dye laser on the treatment response of keloidal and hypertrophic sternotomy scars. Dermatol Surg 2007, 33:152-161.
45. Shah S., Alster T.S. Laser treatment of dark skin: an updated review. Am J Clin Dermatol 2010, 11:1-10.
46. Bhatt N., Alster T.S. Laser surgery in dark skin. Dermatol Surg 2008, 34:184-195.
47. Alster T.S. Laser scar revision: comparison of pulsed dye laser with and without intralesional corticosteroids. Dermatol Surg 2002, 29:25-29.
48. Manuskiatti W., Fitzpatrick R.E. Treatment response of keloidal and hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002, 138:1149-1155.
49. Hermanns J.F., Petit L., Hermanns L.T., et al. Analytic quantification of phototype-related regional skin complexion. Skin Res Technol 2001, 7:168-171.
50. Fiskerstrand E.J., Svaasand L.O., Volden G. Pigmentary changes after pulsed dye laser treatment in 125 northern European patients with port wine stains. Br J Dermatol 1998, 138(3):477-479.
51. Bellew S.G., Weiss M.A., Weiss R.A. Comparison of intense pulsed light to 585-nm long-pulsed pulsed dye laser for treatment of hypertrophic surgical scars: a pilot study. J Drugs Dermatol 2005, 4:448-452.
52. Bowes L.E., Nouri K., Berman B., et al. Treatment of pigmented hypertrophic scars with the 585nm pulsed dye laser and the 532 nm frequency-doubled Nd:YAG laser in the Q-switched and variable pulse modes: a comparative study. Dermatol Surg 2002, 28:714-719.
53. Apfelberg D.B., Maser M.R., White D.N., et al. Failure of carbon dioxide laser excision of keloids. Lasers Surg Med 1989, 9:382-388.
54. Tanzi E.L., Wanitphakdeedecha R., Alster T.S. Fraxel laser indications and long-term follow-up. Aesthet Surg J 2008, 28:61-64.
55. 2 and erbium: YAG laser: preoperative, intraoperative, and postoperative considerations. Plast Reconstr Surg 1999, 103:619-632.
56. Alster T.S., Tanzi E.L. Laser skin resurfacing: ablative and nonablative. Surgery of the skin 2005, 611-624. Elsevier, Philadelphia. J. Robinson, R. Sengelman, D.M. Siegel (Eds.).
57. Alster T.S., West T.B. Resurfacing atrophic facial scars with a high energy, pulsed carbon dioxide laser. Dermatol Surg 1996, 22:151-155.
58. 2 laser resurfacing of atrophic scars. Dermatol Surg 1999, 25:926-930.
59. Tanzi E.L., Alster T.S. Treatment of atrophic facial acne scars with a dual-mode Er: YAG laser. Dermatol Surg 2002, 28:551-555.
60. Alster T.S., Nanni C.A., Williams C.M. Comparison of four carbon dioxide resurfacing lasers: a clinical and histopathologic evaluation. Dermatol Surg 1999, 25:153-159.
61. 2 laser resurfacing. Semin Cutan Med Surg 1996, 15:189-193.
62. 2 laser skin resurfacing: a comparison of scanned and pulsed systems. J Am Acad Dermatol 1997, 37:709-718.
63. 2 laser, erbium: YAG laser, and blended lasers: a 4- to 6-month prospective histologic and clinical study. Lasers Surg Med 2000, 27:362-372.
64. Fitzpatrick R.E., Tope W.D., Goldman M.P., et al. Pulsed carbon dioxide laser, trichloroacetic acid, Baker-Gordon phenol, and dermabrasion: a comparative clinical and histologic study of cutaneous resurfacing in a porcine model. Arch Dermatol 1996, 132:469-471.
65. 2 laser. J Am Acad Dermatol 1999, 40:615-622.
66. Fitzpatrick R.E., Rostan E.F., Marchell N. Collagen tightening induced by carbon dioxide laser versus erbium:YAG laser. Lasers Surg Med 2000, 27:395-403.
67. Katz B.E., MacFarlane D.F. Atypical facial scarring after isotretinoin therapy in a patient with a previous dermabrasion. J Am Acad Dermatol 1994, 30:852-853.
68. 2 laser resurfacing: an evaluation of 500 patients. Dermatol Surg 1998, 24:315-320.
69. Horton S., Alster T.S. Preoperative and postoperative considerations for cutaneous laser resurfacing. Cutis 1999, 64:399-406.
70. Alster T.S., Lupton J.R. Prevention and treatment of side effects and complications of cutaneous laser resurfacing. Plast Reconstr Surg 2002, 109:308-316.
71. 2 laser resurfacing infection rate with and without prophylactic antibiotics. Dermatol Surg 1999, 25:857-861.
72. Alster T.S., Nanni C.A. Famciclovir prophylaxis of herpes simplex virus reactivation after cutaneous laser resurfacing. Dermatol Surg 1997, 25:242-246.
73. Beeson W.H., Rachel J.D. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing. Dermatol Surg 2002, 28:331-336.
74. Fisher A.A. Lasers and allergic contact dermatitis to topical antibiotics, with particular reference to bacitracin. Cutis 1996, 58:252-254.
75. Tanzi E.L., Alster T.S. Comparison of a 1450 nm diode laser and a 1320 nm Nd:YAG laser in the treatment of atrophic facial scars: a prospective clinical and histological study. Dermatol Surg 2004, 30:152-157.
76. Rogachefsky A.S., Hussain M., Goldberg D.J. Atrophic and mixed pattern of acne scars with a 1320 nm Nd:YAG laser. Dermatol Surg 2003, 29:904-908.
77. Friedman P.M., Jih M.H., Skover G.R., et al. Treatment of atrophic facial acne scars with the 1064-nm Q-switched Nd:YAG laser. Arch Dermatol 2004, 140:1337-1341.
78. Friedman P.M., Skover G.R., Payonik G., et al. 3D in-vivo optical skin imaging for topographical quantitative assessment of non-ablative laser technology. Dermatol Surg 2002, 28:199-204.
79. Sobanko JF, Alster TS. Laser skin resurfacing of rhytides and scars. In: Spiegel J, editor. Office based facial plastic surgery, in press.
80. Manstein D., Herron G.S., Sink R.K., et al. Fractional photothermolysis: a new concept for cutaneous remodeling using microscopic patterns of thermal injury. Lasers Surg Med 2004, 34:426-438.
81. Laubach H.J., Tannous Z., Anderson R.R., et al. Skin responses to fractional photothermolysis. Lasers Surg Med 2006, 38:142-149.
82. Walgrave S., Zelickson B., Childs J., et al. Pilot investigation of the correlation between histological and clinical effects of infrared fractional resurfacing lasers. Dermatol Surg 2008, 34:1443-1453.
83. Geronemus R. Fractional photothermolysis: current and future applications. Lasers Surg Med 2006, 38:169-176.
84. Alster T.S., Tanzi E.L., Lazarus E. The use of fractional laser photothermolysis for the treatment of atrophic scars. Dermatol Surg 2007, 33:295-299.
85. Taub A.F. Fractionated delivery systems for difficult to treat clinical applications: acne scarring, melasma, atrophic scarring, striae distensae, and deep rhytides. J Drugs Dermatol 2007, 6:1120-1128.
86. Chrastil B., Glaich A.S., Goldberg L.H., et al. Second-generation 1,550-nm fractional photothermolysis for the treatment of acne scars. Dermatol Surg 2008, 34:1327-1332.
87. Hu S., Chen M.C., Lee M.C., et al. Fractional resurfacing for the treatment of atrophic facial acne scars in Asian skin. Dermatol Surg 2009, 35:826-832.
88. Cho S.B., Le J.H., Choi M.J., et al. Efficacy of the fractional photothermolysis system with dynamic operating mode on acne scars and enlarged pores. Dermatol Surg 2009, 35:108-114.
89. Mahmoud B.H., Srivastava D., Janiga J.J., et al. Safety and efficacy of erbium-doped yttrium aluminum garnet fractionated laser for treatment of acne scars in type IV to VI skin. Dermatol Surg 2010, 36:602-609.
90. Vasily D.B., Cerino M.E., Ziselman E.M., et al. Non-ablative fractional resurfacing of surgical and post-traumatic scars. J Drugs Dermatol 2009, 8:998-1005.
91. Haedersdal M., Morean K.E.R., Beyer D.M., et al. Fractional nonablative 1540 nm laser resurfacing for thermal burn scars: a randomized controlled trial. Lasers Surg Med 2009, 41:189-195.
92. Tierney E.P., Kouba D.J., Hanke C.W. Review of fractional photothermolysis: treatment indications and efficacy. Dermatol Surg 2009, 35:1445-1461.
93. Kunishige J.H., Katz T.M., Goldberg L.H., et al. Fractional photothermolysis for the treatment of surgical scars. Dermatol Surg 2010, 36:538-541.
94. Manstein D., Zurakowski D., Thongsima S., et al. The effects of multiple passes on the epidermal thermal damage pattern in nonablative fractional resurfacing. Lasers Surg Med 2009, 41:149-153.
95. Thongsima S., Zurakowski D., Manstein D. Histological comparison of two different fractional photothermolysis devices operating at 1,550nm. Lasers Surg Med 2010, 42:32-37.
96. Hantash B.M., Bedi V.P., Kapadia B., et al. In vivo histological evaluation of a novel ablative fractional resurfacing device. Lasers Surg Med 2007, 39:96-107.
97. Saluja R., Khoury J., Detwiler S.P., et al. Histologic and clinical response to varying density settings with a fractionally scanned carbon dioxide laser. J Drugs Dermatol 2009, 8:17-20.
98. 2 laser: a novel therapeutic device upon photomodulation of tissue remodeling and cytokine pathway of tissue repair. Dermatol Ther 2009, 22:S8-S15.
99. Waibel J., Beer K., Narurkar V., et al. Preliminary observations on fractional ablative resurfacing devices: clinical impressions. J Drugs Dermatol 2009, 8:481-485.
100. 2 ablative fractional resurfacing. Lasers Surg Med 2008, 40:381-386.
101. Cho S.B., Lee S.J., Kang J.M., et al. The efficacy and safety of 10,600-nm carbon dioxide fractional laser for acne scars in Asian patients. Dermatol Surg 2009, 35:1955-1961.
102. Walgrave S.E., Ortiz A.E., MacFalls H.T., et al. Evaluation of a novel fractional resurfacing device for the treatment of acne scarring. Lasers Surg Med 2009, 41:122-127.
103. Gotkin RH, Sarnoff DS, Cannarozzo G et al. Ablative skin resurfacing with a novel microablative CO2 laser. J Drugs Dermatol 1009;8:138-144.
104. Kim S., Cho K.H. Clinical trial of dual treatment with an ablative fractional laser and a nonablative laser for the treatment of acne scars in Asian patients. Dermatol Surg 2009, 35:1089-1098.
105. Ortiz A.E., Tremaine A.M., Zachary C.B. Long-term efficacy of a fractional resurfacing device. Lasers Surg Med 2010, 42:168-170.
106. Manuskiatti W., Triwongwaranat D., Varothai S., et al. Efficacy and safety of a carbon-dioxide ablative fractional resurfacing device for treatment of atrophic acne scars in Asians. J Am Acad Dermatol 2010, 63:274-283.
107. Weiss E.T., Chapas A., Brightman L., et al. Successful treatment of atrophic postoperative and traumatic scarring with carbon dioxide ablative fractional resurfacing. Arch Dermatol 2010, 146:133-140.
108. Waibel J., Beer K. Ablative fractional laser resurfacing for the treatment of a third-degree burn. J Drugs Dermatol 2009, 8:294-297.
109. Graber E.M., Tanzi E.L., Alster T.S. Side effects and complications of fractional laser photothermolysis: experience with 961 treatments. Dermatol Surg 2008, 34:301-307.
110. Metelitsa A.I., Alster T.S. Fractionated laser skin resurfacing treatment complications: a review. Dermatol Surg 2010, 36:299-306.
111. Alster T.S., Wanitphakdeedecha R. Improvement of post-fractional laser erythema with light-emitting diode photomodulation. Dermatol Surg 2009, 35:813-815.
112. Avram M.M., Tope W.D., Yu T., et al. Hypertrophic scarring of the neck following ablative fractional carbon dioxide laser resurfacing. Lasers Surg Med 2009, 41:185-188.
113. 2 laser resurfacing: four cases. Lasers Surg Med 2009, 41:179-184.
114. Mamelak A.J., Goldberg L.H., Marquez D., et al. Eruptive keratoacanthomas on the legs after fractional photothermolysis: report of two cases. Dermatol Surg 2009, 35:513-518.
115. Foster K.W., Fincher E.F., Moy R.L. Heat-induced " recall" of treatment zone erythema following fractional resurfacing with a combination laser (1320 nm/1440 nm). Arch Dermatol 2008, 144:1398-1399.